These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12085235)

  • 21. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway.
    Fenig E; Szyper-Kravitz M; Yerushalmi R; Lahav M; Beery E; Wasserman L; Gutman H; Nordenberg J
    Oncol Rep; 2002; 9(4):875-7. PubMed ID: 12066225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: involvement of protein kinase Calpha and extracellular signal-regulated kinase mitogen-activated protein kinase.
    Nakagawa S; Fujii T; Yokoyama G; Kazanietz MG; Yamana H; Shirouzu K
    Mol Carcinog; 2003 Nov; 38(3):106-16. PubMed ID: 14587095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
    Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines.
    Lessor TJ; Yoo JY; Xia X; Woodford N; Hamburger AW
    J Cell Physiol; 2000 Jun; 183(3):321-9. PubMed ID: 10797306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin.
    Zi X; Agarwal R
    Biochem Biophys Res Commun; 1999 Sep; 263(2):528-36. PubMed ID: 10491326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
    Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
    Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.
    Harari D; Yarden Y
    Oncogene; 2000 Dec; 19(53):6102-14. PubMed ID: 11156523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.
    Ayllón V; O'connor R
    Oncogene; 2007 May; 26(24):3451-61. PubMed ID: 17160018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterotrimeric G-protein betagamma-dimers in growth and differentiation.
    Schwindinger WF; Robishaw JD
    Oncogene; 2001 Mar; 20(13):1653-60. PubMed ID: 11313913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and differential signaling of heregulins in pancreatic cancer cells.
    Kolb A; Kleeff J; Arnold N; Giese NA; Giese T; Korc M; Friess H
    Int J Cancer; 2007 Feb; 120(3):514-23. PubMed ID: 17096356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2.
    Tikhomirov O; Carpenter G
    J Biol Chem; 2004 Mar; 279(13):12988-96. PubMed ID: 14711810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells.
    Chakravarti P; Henry MK; Quelle FW
    Int J Oncol; 2005 Feb; 26(2):509-14. PubMed ID: 15645137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.
    Yue W; Wang JP; Conaway M; Masamura S; Li Y; Santen RJ
    Endocrinology; 2002 Sep; 143(9):3221-9. PubMed ID: 12193533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular control of cell size.
    Conlon IJ; Dunn GA; Mudge AW; Raff MC
    Nat Cell Biol; 2001 Oct; 3(10):918-21. PubMed ID: 11584274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Connecting signaling and cell cycle progression in growth factor-stimulated cells.
    Jones SM; Kazlauskas A
    Oncogene; 2000 Nov; 19(49):5558-67. PubMed ID: 11114735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin.
    Cocolakis E; Lemay S; Ali S; Lebrun JJ
    J Biol Chem; 2001 May; 276(21):18430-6. PubMed ID: 11278744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.